BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 26657175)

  • 1. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
    Okita K; Ghahremani DG; Payer DE; Robertson CL; Mandelkern MA; London ED
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26657175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
    Okita K; Ghahremani DG; Payer DE; Robertson CL; Dean AC; Mandelkern MA; London ED
    Drug Alcohol Depend; 2016 Apr; 161():163-70. PubMed ID: 26880595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME; Mandelkern MA; Monterosso JR; Hsu E; Robertson CL; Ishibashi K; Dean AC; London ED
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu119. PubMed ID: 25603861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
    Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
    Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
    Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.
    London ED; Berman SM; Voytek B; Simon SL; Mandelkern MA; Monterosso J; Thompson PM; Brody AL; Geaga JA; Hong MS; Hayashi KM; Rawson RA; Ling W
    Biol Psychiatry; 2005 Nov; 58(10):770-8. PubMed ID: 16095568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
    Lee B; London ED; Poldrack RA; Farahi J; Nacca A; Monterosso JR; Mumford JA; Bokarius AV; Dahlbom M; Mukherjee J; Bilder RM; Brody AL; Mandelkern MA
    J Neurosci; 2009 Nov; 29(47):14734-40. PubMed ID: 19940168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered cingulate and insular cortex activation during risk-taking in methamphetamine dependence: losses lose impact.
    Gowin JL; Stewart JL; May AC; Ball TM; Wittmann M; Tapert SF; Paulus MP
    Addiction; 2014 Feb; 109(2):237-47. PubMed ID: 24033715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
    Ballard ME; Dean AC; Mandelkern MA; London ED
    PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography study.
    Spitta G; Gleich T; Rosenthal A; Schubert F; Aydin S; Heinz A; Buchert R; Gallinat J
    Addict Biol; 2024 Jun; 29(6):e13424. PubMed ID: 38899357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural correlates of affect processing and aggression in methamphetamine dependence.
    Payer DE; Lieberman MD; London ED
    Arch Gen Psychiatry; 2011 Mar; 68(3):271-82. PubMed ID: 21041607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
    Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
    Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denial in methamphetamine users: Associations with cognition and functional connectivity in brain.
    Dean AC; Kohno M; Morales AM; Ghahremani DG; London ED
    Drug Alcohol Depend; 2015 Jun; 151():84-91. PubMed ID: 25840750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
    London ED; Simon SL; Berman SM; Mandelkern MA; Lichtman AM; Bramen J; Shinn AK; Miotto K; Learn J; Dong Y; Matochik JA; Kurian V; Newton T; Woods R; Rawson R; Ling W
    Arch Gen Psychiatry; 2004 Jan; 61(1):73-84. PubMed ID: 14706946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling.
    London ED
    Adv Pharmacol; 2016; 76():67-84. PubMed ID: 27288074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain response during visual emotional processing: an fMRI study of alexithymia.
    Deng Y; Ma X; Tang Q
    Psychiatry Res; 2013 Sep; 213(3):225-9. PubMed ID: 23850105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia.
    Berthoz S; Artiges E; Van De Moortele PF; Poline JB; Rouquette S; Consoli SM; Martinot JL
    Am J Psychiatry; 2002 Jun; 159(6):961-7. PubMed ID: 12042184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between excitement symptom severity and extrastriatal dopamine D
    Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals.
    Stewart JL; Connolly CG; May AC; Tapert SF; Wittmann M; Paulus MP
    Addiction; 2014 Mar; 109(3):460-71. PubMed ID: 24329936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [
    Kim JH; Choe YS; Cumming P; Son YD; Kim HK; Joo YH; Kim JH
    Synapse; 2019 Nov; 73(11):e22121. PubMed ID: 31206840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.